New dopamine therapy changes Parkinson’s care: Anant Agarwal

Health Consultant Anant Agarwal says advances in dopamine infusion therapy now allow controlled dosing for Parkinson’s patients, improving symptom management. He also cautions that melatonin is safe only for short-term use, generally up to 90 days. Despite its popularity in bio-hacking circles, prolonged use may interfere with the body’s natural sleep and hormone regulation.